Rachel Rubin
Urology · Bethesda, MDNPI 1750680294
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,675 of the $16,971 with a category attached, or 80.6%. 22 manufacturers reported payments, led by Boston Scientific at 45.7% of the total. Reporting peaked in 2019 at $7,903 and has fallen 95.7% since, to $337 in 2025.
Across 88 payments — averaging $192.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Endo Pharmaceuticals Inc.$5K
- GSK$2K
- Agile Therapeutics, Inc.$450
- Coloplast$211
- Axonics, Inc.$198
- plus $1K from 16 others
Across 18 payments — averaging $4110.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Innovation$74K
What the payments were for
- Consulting fees$13,67581%
- Travel & lodging$8955%
- Food & beverage$2,10012%
- Education$3012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $7,760 |
| Endo Pharmaceuticals Inc. | 5 | $4,697 |
| GSK | 1 | $2,400 |
| Agile Therapeutics, Inc. | 1 | $450 |
| Coloplast | 4 | $211 |
| Axonics, Inc. | 3 | $198 |
| Millicent US Inc | 12 | $197 |
| Tolmar, Inc. | 5 | $176 |
| AMAG Pharmaceuticals, Inc. | 7 | $144 |
| Antares Pharma, Inc. | 5 | $138 |
| Radius Health, Inc. | 5 | $113 |
| AbbVie(2 entities) | 4 | $99 |
| Therapeuticsmd, Inc. | 5 | $85 |
| Astellas Pharma US Inc | 3 | $68 |
| Acerus Pharmaceuticals Corporation | 3 | $61 |
| Amgen | 2 | $45 |
| Pfizer | 2 | $40 |
| Valencia Technologies Corporation | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Cosette Pharmaceuticals Inc. | 1 | $17 |
| Halozyme Inc | 1 | $16 |
| Ambu Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,971 in reported general payments places this provider in the 85th percentile of 274 urology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| YuvafemEstradiol | 24 | $5,143 |
| Estradiol | 25 | $3,192 |
| Estradiol (Twice Weekly)Estradiol | 21 | $2,086 |
| ProgesteroneProgesterone, Micronized | 26 | $1,268 |
Paid to pharmacies, not to this prescriber.
Other urology in Bethesda
- Bartholomew RadolinskiBethesda$90K
- Matthew AllawayCumberland$20.6M
- Benjamin LowentrittBaltimore$549K
- Julio DavalosGlen Burnie$490K
- Sankar KausikBel Air$375K
- Laura GiustoOwings Mills$367K
- Amin HeratiBaltimore$160K
- Rian DicksteinHanover$144K
- Max KatesBaltimore$139K
- Arthur BurnettBaltimore$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.